Record

Reference numberRR/14/18
LevelItem
TitleLetter from Edward Albert Sharpey-Schafer, to Richard Tetley Glazebrook, regarding a paper 'The pharmacology of aconitine, diacetyl-aconitine, benzaconine, and aconine, considered in relation to their chemical constitution' by John Theodore Cash and Wyndham Rowland Dunstan
Date18 January 1898
DescriptionMichael Foster thinks the paper should be considered by both the Physicochemical and the Physiological Committees. Asks if he can suggest a chemist to referee the paper. There is a chemical element to the paper, but the bulk is physiological.

Subject: Physics and Chemistry

[Published in the Philosophical Transactions of the Royal Society]
Extent2p
FormatManuscript
Physical descriptionLetter on paper
Access statusOpen
Related materialDOI: 10.1098/rstb.1898.0004 Vol.190 1898
Related records in the catalogueRR/14/19
RR/14/20
RR/14/21
Fellows associated with this archive
CodeNameDates
NA8017Sharpey-Schafer; Sir; Edward Albert (1850 - 1935)1850 - 1935
NA8225Glazebrook; Sir; Richard Tetley (1854 - 1935)1854 - 1935
NA7124Cash; John Theodore (1854 - 1936)1854 - 1936
NA1313Dunstan; Sir; Wyndham Rowland (1861 - 1949)1861 - 1949
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView